|1.||Micenková, Lenka: 2 articles (01/2014 - 01/2010)|
|2.||Woznicová, Vladana: 2 articles (01/2014 - 01/2010)|
|3.||Vrba, Martin: 2 articles (01/2014 - 01/2010)|
|4.||Masaki, Haruhiko: 2 articles (12/2007 - 12/2007)|
|5.||Mrak, Peter: 2 articles (04/2007 - 01/2003)|
|6.||Zgur-Bertok, Darja: 2 articles (04/2007 - 01/2003)|
|7.||Podlesek, Zdravko: 2 articles (04/2007 - 01/2003)|
|8.||Littnerová, Simona: 1 article (01/2014)|
|9.||de Oliveira, Maria Gabriela Xavier: 1 article (01/2014)|
|10.||Ring, Diana: 1 article (01/2014)|
11/01/2007 - "Previous research in our laboratories has shown that colicin E1 is effective against some Escherichia coli strains responsible for postweaning diarrhea (PWD) in vitro. "
11/01/2007 - "Dietary inclusion of colicin e1 is effective in preventing postweaning diarrhea caused by F18-positive Escherichia coli in pigs."
08/01/2004 - "The efficacies of colicins E1 and N against Escherichia coli strains responsible for postweaning diarrhea and edema disease, two of the most prevalent disease problems for pigs in the United States, were determined in vitro. "
08/01/2004 - "Inhibitory activities of colicins against Escherichia coli strains responsible for postweaning diarrhea and edema disease in swine."
04/01/1990 - "DNA probes for the colicin V, traT, iss, and iu genes were used in this study of four representative ColV plasmids together with 200 Escherichia coli strains isolated from the stools of patients with diarrhea and 146 E. "
02/01/1981 - "Strains of Escherichia coli isolated from random fecal samples, urines of hospitalized and nonhospitalized patients who had urinary tract infections, and blood of patients with septicemia were examined for colicin V production. "
12/01/1993 - "In this study, 91 F165-positive Escherichia coli isolated from calves and piglets with diarrhea or septicemia were characterized with respect to receptor binding specificity, presence of the aerobactin system, production of colicin V, resistance to the bactericidal effects of serum. "
08/01/1990 - "One hundred Escherichia coli isolates from human septicemia were characterized with respect to O serogroups 1, 2, 4, 6, 7, 8, 15, 18, 75 and 78, alpha-hemolysin, carboxylesterase B typing, cytotoxic necrotizing factor, F165 and CS31A fimbrial antigens, aerobactin production, colicins, and antibiotic sensitivity. "
|3.||Breast Neoplasms (Breast Cancer)
11/01/2007 - "coli infections, were individually housed and fed diets containing 0, 11, or 16.5 mg colicin E1/kg diet. "
04/01/2007 - "coli cells from infection by E colicins. "
04/01/1998 - "coli were also studied: ompA, ompFand tolA (predicting epigenetic variation that could help escape infection by phages or colicins)."
06/14/1996 - "The Escherichia coli TolQ protein is a 230-amino acid integral cytoplasmic membrane protein required for the import of group A colicins, for infection by the filamentous phage, and for maintenance of the integrity of the bacterial envelope. "
02/01/1995 - "Hexapeptides derived from three specific regions of the surface loop inhibited infection of cells by the phages and killing by colicin M. "
07/01/1969 - "Investigations on the sensitivity of isolated strains of Shigella flexneri 2a from mass outbreaks of dysentery to colicins of the Shigella sonnei."
11/01/1968 - "[Typing of colicins produced by Sonne dysentery bacteria]."
07/01/1968 - "Investigations on the sensitivity of isolated strains of Shigella flexneri 3a from epidemics of dysentery to colicins of Shigella sonnei."
06/01/1968 - "[Colicinogenicity and sensitivity to colicins of dysentery agents isolated from patients with acute and chronic form of the disease]."
01/01/1968 - "[Colicins of dysentery bacteria and common Escherichia coli isolated from dysentery patients and their typing on the basis of specificity of mutants resistant to them and of monosensitive cultures]."
|4.||DNA (Deoxyribonucleic Acid)
|5.||Proteins (Proteins, Gene)
|1.||Transplantation (Transplant Recipients)